$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Impact of left ventricular hypertrophy on long-term clinical outcomes in hypertensive patients who underwent successful percutaneous coronary intervention with drug-eluting stents 원문보기

Medicine, v.97 no.35, 2018년, pp.e12067 -   

Kim, Yong Hoon (Division of Cardiology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon) ,  Her, Ae-Young (Division of Cardiology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon) ,  Choi, Byoung Geol (Department of Medicine, Korea University Graduate School) ,  Choi, Se Yeon (Department of Medicine, Korea University Graduate School) ,  Byun, Jae Kyeong (Department of Medicine, Korea University Graduate School) ,  Baek, Man Jong (Department of Thoracic and Cardiovascular Surgery) ,  Ryu, Yang Gi (Department of Thoracic and Cardiovascular Surgery) ,  Park, Yoonjee (Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea.) ,  Mashaly, Ahmed (Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea.) ,  Jang, Won Young (Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea.) ,  Kim, Woohyeun (Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea.) ,  Choi, Jah Yeon (Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea.) ,  Park, Eun Jin (Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea.) ,  Na, Jin Oh (Cardiovascular Center,) ,  Choi, Cheol Ung ,  Lim, Hong Euy ,  Kim, Eung Ju ,  Park, Chang Gyu ,  Seo, Hong Seog ,  Rha, Seung-Woon

Abstract AI-Helper 아이콘AI-Helper

AbstractLeft ventricular hypertrophy (LVH) is associated with increased risk for vascular events and mortality. This study investigated 8-year clinical outcomes of hypertensive patients with LVH who underwent percutaneous coronary intervention (PCI) with drug-eluting stents (DES) compared with hyper...

주제어

참고문헌 (25)

  1. [1] Lewington S Clarke R Qizilbash N Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies . Lancet 2002 ; 360 : 1903 – 13 . 12493255 

  2. [2] Vakili BA Okin PM Devereux RB Prognostic implications of left ventricular hypertrophy . Am Heart J 2001 ; 141 : 334 – 41 . 11231428 

  3. [3] Clement DL De Buyzere M Duprez D Left ventricular function and regression of left ventricular hypertrophy in essential hypertension . Am J Hypertens 1993 ; 6 : 14s – 9s . 8466720 

  4. [4] Turakhia MP Schiller NB Whooley MA Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study) . Am J Cardiol 2008 ; 102 : 1131 – 5 . 18940278 

  5. [5] Westerhout CM Lauer MS James S Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women . Eur Heart J 2007 ; 28 : 2064 – 9 . 17600040 

  6. [6] Sullivan JM Vander Zwaag RV el-Zeky F Left ventricular hypertrophy: effect on survival . J Am Coll Cardiol 1993 ; 22 : 508 – 13 . 8335822 

  7. [7] Devereux RB Alonso DR Lutas EM Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings . Am J Cardiol 1986 ; 57 : 450 – 8 . 2936235 

  8. [8] Lang RM Bierig M Devereux RB Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology . J Am Soc Echocardiogr 2005 ; 18 : 1440 – 63 . 16376782 

  9. [9] The Joint European Society of Cardiology/American College of Cardiology Committee . Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction . Eur Heart J 2000 ; 21 : 1502 – 13 . 10973764 

  10. [10] Lyons D Webster J Benjamin N Angiotensin II: adrenergic sympathetic constrictor actions in humans . Circulation 1995 ; 91 : 1457 – 60 . 7867187 

  11. [11] Cirillo P De Rosa S Pacileo M Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease . J Thromb Haemost 2008 ; 6 : 726 – 36 . 18284603 

  12. [12] Zou Y Nagai R Yam Azaki T Urotensin II induces hypertrophic response s in cultured cardiomyocytes from neonatal rats . FEBS Lett 2001 ; 508 : 57 – 60 . 11707268 

  13. [13] Ritschel V Shetelig C Seljeflot I Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction . Sci Rep 2017 ; 7 : 11945 . 28931920 

  14. [14] Wang JW Fontes MSC Wang X Leukocytic toll-like receptor 2 deficiency preserves cardiac function and reduces fibrosis in sustained pressure overload . Sci Rep 2017 ; 7 : 9193 . 28835616 

  15. [15] Goldsmith SR Hasking GJ Miller E Angiotensin II and sympathetic activity in patients with congestive heart failure . J Am Coll Cardiol 1993 ; 21 : 1107 – 13 . 8384645 

  16. [16] Vaughan DE Lazos SA Tong K Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis . J Clin Invest 1995 ; 95 : 995 – 1001 . 7884001 

  17. [17] Haider AW Larson MG Benjamin EJ Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death . J Am Coll Cardiol 1998 ; 32 : 1454 – 9 . 9809962 

  18. [18] Wachtell K Okin PM Olsen MH Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE study . Circulation 2007 ; 116 : 700 – 5 . 17664372 

  19. [19] Artham SM Lavie CJ Milani RV Clinical impact of left ventricular hypertrophy and implications for regression . Prog Cardiovasc Dis 2009 ; 52 : 153 – 67 . 19732607 

  20. [20] Schillaci G Verdecchia P Porcellati C Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension . Hypertension 2000 ; 35 : 580 – 6 . 10679501 

  21. [21] Liao Y Cooper RS McGee DL The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults . JAMA 1995 ; 273 : 1592 – 7 . 7745772 

  22. [22] Park JS Shin JS Lee YH Left ventricular hypertrophy on long-term cardiovascular outcomes in patients with ST-elevation myocardial infarction . Clin Exp Hypertens 2015 ; 37 : 674 – 9 . 26151825 

  23. [23] Camici PG Olivotto I Rimoldi OE The coronary circulation and blood flow in left ventricular hypertrophy . J Mol Cell Cardiol 2012 ; 52 : 857 – 64 . 21924273 

  24. [24] East MA Jollis JG Nelson CL The influence of left ventricular hypertrophy on survival in patients with coronary artery disease: do race and gender matter? J Am Coll Cardiol 2003 ; 41 : 949 – 54 . 12651039 

  25. [25] Brown DL Effect of left ventricular hypertrophy on long-term survival of patients with coronary artery disease following percutaneous coronary intervention . Heart Int 2009 ; 4 : e9 . 21977285 

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로